Atrial Fibrillation Therapy, Kartoniert / Broschiert

Kurzbeschreibung

Discussing the latest diagnostic tools for selecting AF patients for specific therapies, this guide presents recent research in a highly practical, easily referenced format, and covers new guidelines as well as ongoing trials with novel antithrombotic drugs.

Inhaltsangabe

Epidemiology and health burden of Atrial Fibrillation (AF).- The atrial Fibrillation Substrate: from genes to remodeling and neural mechanisms.- Stroke Prevention in Atrial Fibrillation.- Pharmacologic therapy of Atrial Fibrillation: Present and Future.- Nonpharmacologic therapy of Atrial Fibrillation: Strengths and Weaknesses.

Klappentext

The paradigm for atrial fibrillation (AF) management has changed significantly in recent years. A new era has begun for the prevention of one of the most tremendous complication of AF, stroke. Prevention of ischemic stroke in AF patients with oral anticoagulants represents a huge challenge because of the narrow therapeutic change of these drugs, interindividual and intraindividual variability, and the unsatisfactory time in therapeutically range (TTR) with this type of medication.
New guidelines have emerged as a result of new mechanisms for initiation and perpetuation for pharmacotherapy to cure AF and trials with new classes of antithrombotic drugs are ongoing. The treatment of AF is still in its infancy, but recent research is revealing how it can be applied with optimal efficacy. This book assists trainees, recertifying physicians, practicing physicians and other professional staff in internal medicine, cardiology, emergency medicine, and clinical pharmacology to apply new diagnostic tools for selecting the best treatment options for AF patients.